Knight Therapeutics, Inc. (GUD.TO)
10.25
+0.02
(+0.20%)
CAD |
TSX |
Sep 18, 16:00
Knight Therapeutics Price : 10.25 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 10.25 | 10.27 | 10.10 | 10.25 | 59696.00 |
| Sep 17, 2026 | 10.07 | 10.34 | 10.06 | 10.23 | 57613.00 |
| Sep 16, 2026 | 9.99 | 10.15 | 9.86 | 10.01 | 74380.00 |
| Sep 15, 2026 | 9.97 | 10.11 | 9.89 | 9.96 | 45286.00 |
| Sep 14, 2026 | 9.89 | 10.09 | 9.85 | 10.02 | 57025.00 |
| Sep 11, 2026 | 9.75 | 9.86 | 9.74 | 9.85 | 197509.0 |
| Sep 10, 2026 | 9.88 | 9.93 | 9.65 | 9.73 | 82049.00 |
| Sep 09, 2026 | 9.88 | 9.94 | 9.86 | 9.90 | 42211.00 |
| Sep 08, 2026 | 9.90 | 9.94 | 9.80 | 9.90 | 40411.00 |
| Sep 04, 2026 | 9.95 | 10.05 | 9.85 | 10.01 | 44902.00 |
| Sep 03, 2026 | 9.60 | 10.10 | 9.58 | 10.04 | 488532.0 |
| Sep 02, 2026 | 9.65 | 9.97 | 9.61 | 9.67 | 86258.00 |
| Sep 01, 2026 | 9.60 | 9.70 | 9.56 | 9.64 | 35761.00 |
| Aug 31, 2026 | 9.50 | 9.70 | 9.48 | 9.66 | 55797.00 |
| Aug 28, 2026 | 9.60 | 9.61 | 9.47 | 9.47 | 39900.00 |
| Aug 27, 2026 | 9.33 | 9.76 | 9.33 | 9.59 | 35919.00 |
| Aug 26, 2026 | 9.47 | 9.80 | 9.47 | 9.76 | 42391.00 |
| Aug 25, 2026 | 9.67 | 9.91 | 9.67 | 9.75 | 82018.00 |
| Aug 24, 2026 | 9.66 | 9.83 | 9.38 | 9.66 | 91321.00 |
| Aug 21, 2026 | 9.70 | 9.74 | 9.61 | 9.66 | 39093.00 |
| Aug 20, 2026 | 9.84 | 9.93 | 9.63 | 9.63 | 53620.00 |
| Aug 19, 2026 | 9.73 | 9.89 | 9.69 | 9.82 | 55011.00 |
| Aug 18, 2026 | 9.75 | 9.80 | 9.61 | 9.73 | 53272.00 |
| Aug 17, 2026 | 9.34 | 9.80 | 9.30 | 9.78 | 96071.00 |
| Aug 14, 2026 | 9.21 | 9.32 | 9.20 | 9.32 | 122188.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| HLS Therapeutics, Inc. | 3.91 |
| Bausch Health Cos., Inc. | 7.92 |
| Cipher Pharmaceuticals, Inc. | 14.67 |
| BioSyent, Inc. | 15.73 |
| Revive Therapeutics Ltd. | 0.02 |
Price Related Metrics
| PE Ratio | 68.24 |
| PS Ratio | 1.854 |
| PEG Ratio | 0.0149 |
| Price to Book Value | 1.261 |
| Price to Free Cash Flow | 10.25 |
| Earnings Yield | 1.47% |
| Market Cap | 1.007B |
| PEGY Ratio | 0.0149 |
| Operating PE Ratio | 38.44 |
| Normalized PE Ratio | 50.59 |